- Report
- September 2026
- 192 Pages
Global
From €3236EUR$3,545USD£2,773GBP
€3595EUR$3,939USD£3,081GBP
- Report
- September 2026
- 194 Pages
Global
From €3236EUR$3,545USD£2,773GBP
€3595EUR$3,939USD£3,081GBP
- Report
- February 2026
- 250 Pages
Global
From €4098EUR$4,490USD£3,512GBP
- Report
- September 2026
- 177 Pages
Global
From €5339EUR$5,850USD£4,575GBP
- Report
- July 2026
- 120 Pages
Global
From €4335EUR$4,750USD£3,715GBP
- Report
- August 2026
- 143 Pages
Global
From €3605EUR$3,950USD£3,089GBP
- Report
- January 2026
- 143 Pages
Global
From €3605EUR$3,950USD£3,089GBP
- Report
- June 2026
- 200 Pages
Global
From €2729EUR$2,990USD£2,339GBP
- Report
- February 2026
- 200 Pages
Global
From €2729EUR$2,990USD£2,339GBP
- Report
- September 2026
- 199 Pages
Global
From €3236EUR$3,545USD£2,773GBP
€3595EUR$3,939USD£3,081GBP
- Report
- September 2026
- 181 Pages
Global
From €3236EUR$3,545USD£2,773GBP
€3595EUR$3,939USD£3,081GBP
- Report
- September 2026
- 180 Pages
Global
From €3236EUR$3,545USD£2,773GBP
€3595EUR$3,939USD£3,081GBP
- Report
- February 2026
- 250 Pages
Global
From €4098EUR$4,490USD£3,512GBP
- Report
- December 2025
- 90 Pages
Global
From €5431EUR$5,950USD£4,654GBP
- Report
- April 2026
- 135 Pages
Global
From €2737EUR$2,999USD£2,346GBP
€3650EUR$3,999USD£3,128GBP
- Report
- March 2026
- 147 Pages
Global
From €2737EUR$2,999USD£2,346GBP
€3650EUR$3,999USD£3,128GBP
- Report
- September 2026
- 480 Pages
Global
From €5339EUR$5,850USD£4,575GBP
- Report
- September 2026
- 382 Pages
Global
From €5339EUR$5,850USD£4,575GBP
- Report
- February 2026
- 250 Pages
Global
From €4098EUR$4,490USD£3,512GBP
- Report
- February 2026
- 250 Pages
Global
From €4098EUR$4,490USD£3,512GBP

Asthma is a chronic respiratory condition that affects the airways of the lungs. It is characterized by inflammation, narrowing of the airways, and increased mucus production, which can lead to difficulty breathing, wheezing, and coughing. Asthma is one of the most common chronic diseases in the world, and is a major cause of morbidity and mortality.
The asthma market within the context of pulmonary medicine is a rapidly growing sector, with a wide range of products and services available to treat and manage the condition. These include inhalers, nebulizers, and other devices to deliver medication, as well as monitoring and diagnostic tools. In addition, there are a variety of medications available to treat asthma, including corticosteroids, bronchodilators, and leukotriene modifiers.
Some of the major companies in the asthma market include GlaxoSmithKline, Merck, Novartis, Boehringer Ingelheim, and AstraZeneca. Show Less Read more